Back To Search Results

Osteoma Cutis

Editor: Shane R. Sergent Updated: 5/23/2023 12:29:41 PM

Introduction

Osteoma cutis or cutaneous ossification is a rare and benign dermatological disease characterized by bone formation in the dermis or subcutaneous tissue. It can be either primary when it occurs de novo without a pre-existing disease or secondary when it develops in association with an underlying condition such as trauma, neoplastic or inflammatory diseases.[1] Osteoma cutis can affect children as well as adults. Primary osteoma cutis accounts for 15% of the patients, whereas secondary osteoma cutis represents 85% of the cases. The histogenesis of this dermatological condition has not been fully established.[2]

Etiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Etiology

Osteoma cutis can be either primary or secondary. Osteoma cutis is classified as primary when there is no preexisting lesion. Primary osteoma cutis can occur in isolation or in association with metabolic syndrome.[3]

Osteoma cutis is secondary when it is associated with inflammatory processes, scars, dysembryoplasia, or neoplasia.

Some authors have found a correlation between osteoma cutis and chronic acne.[4] About 85% of osteoma cutis arise as a result of prolonged acne. This is reflected in various sites where osteoma cutis develops, including the face in females and the scalp or chest in males.

Recently, some authors have demonstrated a relationship of osteoma cutis to GNAS1 gene mutations, which is a key regulatory gene in progressive osseous heteroplasia and Albright hereditary osteodystrophy.[5]

Epidemiology

Osteoma cutis accounts for 14% of all cutaneous ossifications.[6] Osteoma cutis can affect adults as well as children. There is a female predominance in osteoma cutis with a peak incidence in the second and third decades.[7] Osteoma cutis can be primary or secondary, which can be due to either inflammatory or neoplastic processes.[7]

The most common locations of osteoma cutis are the face in females and the scalp in males. Other sites of involvement include the breasts, the buttocks, and the extremities. Rarely, osteoma cutis has been seen in mucosae such as the tongue, which is also called osteoma mucosae or osseous choristoma.[2]

Pathophysiology

The mechanism of the formation of osteoma cutis has not been fully established. Several theories have been proposed ranging from hamartomas to nevoid tumors.[7] The most recognized hypothesis is fibroblast metaplasia. According to one theory, the development of osteoma cutis may result from the metaplasia of fibroblasts to osteoblasts secondary to the alterations of the genes that regulate bone formation.[8] In fact, the technique of in situ hybridizations demonstrated that dermal fibroblasts could differentiate into osteoblasts resulting in osteonectin production and increased collagen type 1.[9] Another hypothesis stipulated that primitive mesenchymal cells usually differentiate into osteoblasts but migrate to an ectopic location.[9] According to some authors, skin ossification may also result from gene mutations.

Histopathology

Histologically, osteoma cutis is characterized by the existence of dense eosinophilic deposits in the subcutaneous tissue and the dermis. There are bony spicules with prominent cement lines and calcification. Bony spicules can sometimes perforate the epidermis through a process of transepidermal elimination. There is no associated cartilage formation since the majority of bone formation arises through membranous ossification. Osteoma cutis may demonstrate osteoblasts, osteoclasts, and osteocytes. In large deposits, Haversian systems can be observed. Rarely, bone marrow elements are identified.[10]

Perforating osteoma cutis is a sporadic and peculiar form characterized by a central crater enclosed by squamous epithelium, corresponding to a transepidermal elimination channel.[11]

The immunohistochemical study, as well as special stains, are usually not contributory to the diagnosis of osteoma cutis.

History and Physical

The clinical presentation of osteoma cutis is variable and can range from asymptomatic single to multiple lesions. They range in size from 0.1 cm to 5.0 cm.[7] These lesions may present as papules, plaques, nodules, or as miliary lesions. On palpation, they are hard and can sometimes be responsible for skin discoloration that becomes white or yellowish.[12]

In rare cases, the overlying epidermis may be ulcerated with the release of bony spicules. This rare form corresponds to perforating osteoma cutis.[13]

There are four distinct clinical variants of osteoma cutis:[14]

  • Solitary: Occurs anywhere on the skin as a solitary nodule
  • Widespread: Characterized by the presence of multiple generalized osteomas that arise in the neonatal period 
  • Plate-like: Is often present at birth or grows during the first years of life
  • Multiple miliary osteomas: Characterized by the presence of multiple punctate foci of bone tissue inside the skin[15]

For the diagnosis of plate-like osteoma cutis to be made, four criteria are required, including:[16]

  1. The presence of a bony plate since birth
  2. The absence of metabolic disorder
  3. The presence or not of osteomas elsewhere in the body
  4. The absence of trauma, infection or other underlying events

Physical examination:

Physical examination of patients with osteoma cutis is crucial in order to eliminate dysmorphic features. Primary osteoma cutis can occur in association with progressive osseous heteroplasia, Albright's hereditary osteodystrophy, or fibrodysplasia of progressive ossification.

Progressive osseous heteroplasia:

Progressive osseous heteroplasia (POH) is a rare entity, which can be either sporadic or an autosomal dominant inherited disease. It is characterized by progressive ossification of the dermis in infancy. Whereas, during childhood, there is progressive ossification of the subcutaneous and deep connective tissue. This disease is not accompanied by endocrinological anomalies. Its clinical course is slower in adulthood and may result in ankyloses of the joints as well as growth retardation of the limbs.[17]

Albright's hereditary osteodystrophy:

Albright's hereditary osteodystrophy (AHO) is a disease clinically characterized by short stature, a round face, obesity, and mental retardation. It can be associated with osteoma cutis (25-50%) and with endocrinological abnormalities.[18]

Evaluation

Serum Calcium and Parathyroid Hormone Levels

Serum calcium and parathyroid hormone levels are performed to rule out Albright’s hereditary osteodystrophy.

Conventional soft tissue radiographs, computed tomography (CT) scans, or ultrasonography of the skin can help to evaluate calcification.

Conventional 2D Radiographs

The conventional 2D radiograph is an imaging study that poses diagnostic difficulties, especially regarding the interpretation and the location of osteoma cutis.[7] 

Cone-beam CT:

Cone-beam CT, with its three-dimensional (3D) capabilities, is a beneficial and accurate imaging modality that helps to detect and establish the diagnosis of osteoma cutis.[7] 

Osteoma cutis is a radiopaque regularly outlined lesion that can occasionally have a radiolucent center. The density of osteoma cutis is identical to the bone. Different shapes of osteoma cutis are described, including donut-or snowflake-like or washer-shaped.[7]

Skin Biopsy

The histopathological examination of the cutaneous biopsy confirms with certainty the diagnosis of osteoma cutis.

Treatment / Management

The treatment modalities of osteoma cutis depend on several factors, including its severity, extension, location, and etiology.[19](B3)

There are several treatment options proposed in the literature. Among the different treatment options, we can distinguish between non-invasive and invasive modalities.

Non-invasive treatment options include the application of tretinoin cream with limited results essentially in small and superficial lesions.[19][20](B3)

Invasive treatment modalities include a combination of dermabrasion and punch biopsy, erbium:yttrium-aluminum-garnet (YAG) laser, scalpel incisions, curettage, and CO2 laser.

Ablative laser procedures using CO2 and erbium:YAG lasers may induce cutaneous pigmentary changes. Recently, some authors successfully performed non-ablative Q-switched neodymium:YAG laser treatments for miliary osteoma that did not induce pigmentary changes.[2](B3)

Concerning secondary osteoma cutis, the associated metabolic abnormalities must be investigated and treated accordingly. For instance, patients with pseudohypoparathyroidism may need calcitriol and calcium replacement therapy when hypocalcemia occurs.[3](B3)

Differential Diagnosis

Histological differential diagnosis:

  • Pilomatrixoma in its ossified form
  • Osteochondroma 
  • Ossified hair follicle (for example, in the case of a melanocytic nevus)
  • Osteosarcoma in its extraskeletal form located in the dermis or in the subcutaneous tissue
  • Cutaneous calcinosis

Radiological differential diagnosis :

  • Calcified phleboliths
  • Calcified nodules resulting from surgical clips, wires, or sutures may radiologically mimick osteoma cutis.

Prognosis

Osteoma cutis is a benign tumor that never metastasizes or infiltrates the surrounding structures. The prognosis of this lesion is excellent.

Complications

Ablative laser procedures using CO2 and erbium:YAG lasers may induce cutaneous pigmentary changes.

Consultations

  • Dermatologist
  • Plastic surgeon
  • Dermatopathologist

Deterrence and Patient Education

Patients should consult a dermatologist when they detect any firm nodule in their skin and receive education regarding the clinical course, outcome, and treatment of osteoma cutis. Health care practitioners should notify patients about educational websites. The latter is very helpful in understanding this benign lesion, its etiology, outcome, and treatment. Patient tutoring plays a very crucial role in the deterrence of the processes that can cause osteoma cutis. The patients should also be educated about the importance of regular follow-up and the treatments they are taking.

Pearls and Other Issues

When confronted with primary osteoma cutis, it is prudent to perform a thorough clinical history and a meticulous physical examination (that can disclose dysmorphic features) and seek laboratory signs of pseudohypoparathyroidism, including elevated PTH and hypocalcemia.

Enhancing Healthcare Team Outcomes

An interprofessional team best treats osteoma cutis. This team should include a primary care clinician, a dermatologist, a plastic surgeon, and a dermatopathologist. The primary care clinician can further evaluate and treat the underlying causes in secondary osteoma cutis. Patients will have better outcomes when the team communicates effectively.

References


[1]

Pinzón-Osorio CA, Gomez AP, Álvarez-Mira DM. Bilateral osteoma cutis in a Peach-Faced Lovebird (Agapornis roseicollis). The Journal of veterinary medical science. 2020 May 30:82(5):536-540. doi: 10.1292/jvms.19-0656. Epub 2020 Apr 2     [PubMed PMID: 32238670]


[2]

Barolet AC, Litvinov IV, Barolet D. Multiple miliary osteoma cutis treatment response to Q-switched Nd:YAG laser: A case report. SAGE open medical case reports. 2020:8():2050313X20910562. doi: 10.1177/2050313X20910562. Epub 2020 Mar 4     [PubMed PMID: 32180982]

Level 3 (low-level) evidence

[3]

Ward S, Sugo E, Verge CF, Wargon O. Three cases of osteoma cutis occurring in infancy. A brief overview of osteoma cutis and its association with pseudo-pseudohypoparathyroidism. The Australasian journal of dermatology. 2011 May:52(2):127-31. doi: 10.1111/j.1440-0960.2010.00722.x. Epub 2011 Jan 12     [PubMed PMID: 21605097]

Level 3 (low-level) evidence

[4]

Thielen AM, Stucki L, Braun RP, Masouyé I, Germanier L, Harms M, Salomon D, Borradori L. Multiple cutaneous osteomas of the face associated with chronic inflammatory acne. Journal of the European Academy of Dermatology and Venereology : JEADV. 2006 Mar:20(3):321-6     [PubMed PMID: 16503897]

Level 3 (low-level) evidence

[5]

Elli FM, Barbieri AM, Bordogna P, Ferrari P, Bufo R, Ferrante E, Giardino E, Beck-Peccoz P, Spada A, Mantovani G. Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia: first Italian series. Bone. 2013 Oct:56(2):276-80. doi: 10.1016/j.bone.2013.06.015. Epub 2013 Jun 21     [PubMed PMID: 23796510]


[6]

Coutinho I, Teixeira V, Cardoso JC, Reis JP. Plate-like osteoma cutis: nothing but skin and bone? BMJ case reports. 2014 May 5:2014():. doi: 10.1136/bcr-2013-202901. Epub 2014 May 5     [PubMed PMID: 24798356]

Level 3 (low-level) evidence

[7]

Alhazmi D, Badr F, Jadu F, Jan AM, Abdulsalam Z. Osteoma Cutis of the Face in CBCT Images. Case reports in dentistry. 2017:2017():8468965. doi: 10.1155/2017/8468965. Epub 2017 May 30     [PubMed PMID: 28638666]

Level 3 (low-level) evidence

[8]

Mahy PR, Urist MR. Experimental heterotopic bone formation induced by bone morphogenetic protein and recombinant human interleukin-1B. Clinical orthopaedics and related research. 1988 Dec:(237):236-44     [PubMed PMID: 3263906]

Level 3 (low-level) evidence

[9]

Myllylä RM, Haapasaari KM, Palatsi R, Germain-Lee EL, Hägg PM, Ignatius J, Tuukkanen J. Multiple miliary osteoma cutis is a distinct disease entity: four case reports and review of the literature. The British journal of dermatology. 2011 Mar:164(3):544-52. doi: 10.1111/j.1365-2133.2010.10121.x. Epub 2011 Feb 17     [PubMed PMID: 21062265]

Level 3 (low-level) evidence

[10]

Delaleu J, Cordoliani F, Bagot M, Bouaziz JD, Vignon-Pennamen MD, Lepelletier C. [Miliary osteoma cutis of the face]. Annales de dermatologie et de venereologie. 2020 Apr:147(4):313-315. doi: 10.1016/j.annder.2020.01.008. Epub 2020 Feb 18     [PubMed PMID: 32081454]


[11]

Grandhe N, Dogra S, Saikia U, Handa S. Acquired perforating primary osteoma cutis. Acta dermato-venereologica. 2004:84(6):489-90     [PubMed PMID: 15844650]

Level 3 (low-level) evidence

[12]

Bouraoui S, Mlika M, Kort R, Cherif F, Lahmar A, Sabeh M. Miliary osteoma cutis of the face. Journal of dermatological case reports. 2011 Dec 12:5(4):77-81. doi: 10.3315/jdcr.2011.1082. Epub     [PubMed PMID: 22408708]

Level 3 (low-level) evidence

[13]

Cohen PR. Perforating osteoma cutis: case report and literature review of patients with a solitary perforating osteoma cutis lesion. Dermatology online journal. 2018 Mar 15:24(3):. pii: 13030/qt6kt5n92w. Epub 2018 Mar 15     [PubMed PMID: 29634878]

Level 3 (low-level) evidence

[14]

Orlando G, Salmaso R, Piaserico S. A Case of Secondary Osteoma Cutis Associated with Lichen Planopilaris. Acta dermato-venereologica. 2019 Nov 1:99(12):1190-1191. doi: 10.2340/00015555-3295. Epub     [PubMed PMID: 31449318]

Level 3 (low-level) evidence

[15]

Sethuraman G, Malhotra AK, Khaitan BK, Kumar R, Sharma VK, Kabra M, Singh MK. Osteoma cutis in pseudohypoparathyroidism. Clinical and experimental dermatology. 2006 Mar:31(2):225-7     [PubMed PMID: 16487097]

Level 3 (low-level) evidence

[16]

Orme CM, Hale CS, Meehan SA, Long W. Plate-like osteoma cutis. Dermatology online journal. 2014 Dec 16:20(12):. pii: 13030/qt9pn8q4dc. Epub 2014 Dec 16     [PubMed PMID: 25526332]

Level 3 (low-level) evidence

[17]

Kaplan FS, Shore EM. Progressive osseous heteroplasia. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2000 Nov:15(11):2084-94     [PubMed PMID: 11092391]


[18]

Mantovani G. Clinical review: Pseudohypoparathyroidism: diagnosis and treatment. The Journal of clinical endocrinology and metabolism. 2011 Oct:96(10):3020-30. doi: 10.1210/jc.2011-1048. Epub 2011 Aug 3     [PubMed PMID: 21816789]


[19]

Cohen AD, Chetov T, Cagnano E, Naimer S, Vardy DA. Treatment of multiple miliary osteoma cutis of the face with local application of tretinoin (all-trans-retinoic acid): a case report and review of the literature. The Journal of dermatological treatment. 2001 Sep:12(3):171-3     [PubMed PMID: 12243710]

Level 3 (low-level) evidence

[20]

Fulton JE Jr. Dermabrasion-Loo-punch-excision technique for the treatment of acne-induced osteoma cutis. The Journal of dermatologic surgery and oncology. 1987 Jun:13(6):655-9     [PubMed PMID: 2953769]

Level 3 (low-level) evidence